Improvement of rat islet viability during transplantation: Validation of pharmacological approach to induce VEGF overexpression

Cell Transplantation

Volumn 20, Issue 9, 2011, Pages 1333-1342

  Langlois, A ^a   Bietiger, W ^a   Seyfritz, E ^a   Maillard, E ^a   Vivot, K ^a   Peronet, C ^a   Meyer, N ^b   Kessler, L ^b,c   Jeandidier, N ^b,c   Pinget, M ^a,b,c   Sigrist, S ^a  

^a Ctr Europ d'Etud du Diabete   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c HÔPITAL CIVIL   (France)

Author keywords

Angiogenesis; Deferoxamine (DFO); Gene therapy; Hypoxia inducible factor 1 (HIF 1 ); Islet transplantation; Vascular endothelial growth factor (VEGF)

Indexed keywords

ACTIN; ADENOVIRUS VECTOR; BETA GALACTOSIDASE; C PEPTIDE; DEFEROXAMINE; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN; VASCULOTROPIN 165;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL VIABILITY; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GRAFT FAILURE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; METABOLIC REGULATION; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; REVASCULARIZATION; SURVIVAL; VALIDATION PROCESS;

ADENOVIRIDAE INFECTIONS; ANIMALS; BODY WEIGHT; DEFEROXAMINE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; RATS; RATS, INBRED LEW; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; TISSUE SURVIVAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ADENOVIRIDAE; ANIMALIA; RATTUS;

EID: 80855129564     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X557182     Document Type: Article

References (53)

1. Agani F.; Semenza G. L. Mersalyl is a novel inducer of vascular endothelial growth factor gene expression and hypoxia-inducible factor 1 activity. Mol. Pharmacol. 54:749-754; 1998
2. Boker A.; Rothenberg L.; Hernandez C.; Kenyon N. S.; Ricordi C.; Alejandro R. Human islet transplantation: Update. World J. Surg. 25:481-486; 2001.
3. Brissova M.; Shostak A.; Shiota M.; Wiebe P. O.; Poffenberger G.; Kantz J.; Chen Z.; Carr C.; Jerome W. G.; Chen J.; Baldwin H. S.; Nicholson W.; Bader D. M.; Jetton T.; Gannon M.; Powers A. C. Pancreatic islet production of vascular endothelial growth factor-a is essential for islet vascularization, revascularization, and function. Diabetes 55:2974-2985; 2006.
4. Carlsson P. O.; Palm F.; Andersson A.; Liss P. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes 50:489-495; 2001.
5. Carmeliet P.; Ferreira V.; Breier G.; Pollefeyt S.; Kieckens L.; Gertsenstein M.; Fahrig M.; Vandenhoeck A.; Harpal K.; Eberhardt C.; Declercq C.; Pawling J.; Moons L.; Collen D.; Risau W.; Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439; 1996.
6. Cheng K.; Fraga D.; Zhang C.; Kotb M.; Gaber A. O.; Guntaka R. V.; Mahato R. I. Adenovirus-based vascular endothelial growth factor gene delivery to human pancreatic islets. Gene Ther. 11:1105-1116; 2004.
7. Cheng Y.; Liu Y. F.; Zhang J. L.; Li T. M.; Zhao N. Elevation of vascular endothelial growth factor production and its effect on revascularization and function of graft islets in diabetic rats. World J. Gastroenterol. 13:2862-2866; 2007.
8. Connolly D. T.; Heuvelman D. M.; Nelson R.; Olander J. V.; Eppley B. L.; Delfino J. J.; Siegel N. R.; Leimgruber R. M.; Feder J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 84:1470-1478; 1989.
9. Csete M. E.; Benhamou P. Y.; Drazan K. E.; Wu L.; McIntee D. F.; Afra R.; Mullen Y.; Busuttil R. W.; Shaked A. Efficient gene transfer to pancreatic islets mediated by adenoviral vectors. Transplantation 59:263-268; 1995.
10. Davalli A. M.; Ogawa Y.; Scaglia L.; Wu Y. J.; Hollister J.; Bonner-Weir S.; Weir G. C. Function, mass, and replication of porcine and rat islets transplanted into diabetic nude mice. Diabetes 44:104-111; 1995.
11. Davalli A. M.; Scaglia L.; Zangen D. H.; Hollister J.; Bonner-Weir S.; Weir G. C. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 45:1161-1167; 1996.
12. David A. L.; Torondel B.; Zachary I.; Wigley V.; Abi-Nader K.; Mehta V.; Buckley S. M.; Cook T.; Boyd M.; Rodeck C. H.; Martin J.; Peebles D. M. Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep. Gene Ther. 15:1344-1350; 2008.
13. Epstein A. C.; Gleadle J. M.; McNeill L. A.; Hewitson K. S.; O'Rourke J.; Mole D. R.; Mukherji M.; Metzen E.; Wilson M. I.; Dhanda A.; Tian Y. M.; Masson N.; Hamilton D. L.; Jaakkola P.; Barstead R.; Hodgkin J.; Maxwell P. H.; Pugh C. W.; Schofield C. J.; Ratcliffe P. J. C. Elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107:43-54; 2001.
14. Fernández-Real J. M.; López-Bermejo A.; Ricart W. Cross-talk between iron metabolism and diabetes. Diabetes 51:2348-2354; 2002.
15. Ferrara N. Vascular endothelial growth factor. Arterioscler. Thromb. Vasc. Biol. 29:789-791; 2009.
16. Henkel A. W.; Bieger S. C. Quantification of proteins dissolved in an electrophoresis sample buffer. Anal. Biochem. 223:329-331; 1994.
17. Ivan M.; Kondo K.; Yang H.; Kim W.; Valiando J.; Ohh M.; Salic A.; Asara J. M.; Lane W. S.; Kaelin, Jr. W. G. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing. Science 292:464-468; 2001.
18. Jansson L.; Carlsson P. O. Graft vascular function after transplantation of pancreatic islets. Diabetologia 45:749-763; 2002.
19. Jeong J. W.; Bae M. K.; Ahn M. Y.; Kim S. H.; Sohn T. K.; Bae M. H.; Yoo M. A.; Song E. J.; Lee K. J.; Kim K. W. Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell 111:709-720; 2002.
20. Kumar A.; Lawrence, Jr. J. C.; Jung D. Y.; Ko H. J.; Keller S. R.; Kim J. K.; Magnuson M. A.; Harris T. E. Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole body glucose and lipid metabolism. Diabetes 59:1397-1406; 2010.
21. Kuroda M.; Oka T.; Oka Y.; Yamochi T.; Ohtsubo K.; Mori S.; Watanabe T.; Machinami R.; Ohnishi S. Colocalization of vascular endothelial growth factor (vascular permeability factor) and insulin in pancreatic islet cells. J. Clin. Endocrinol. Metab. 80:3196-3200; 1995.
22. Lai Y.; Schneider D.; Kidszun A.; Hauck-Schmalenberger I.; Breier G.; Brandhorst D.; Brandhorst H.; Iken M.; Brendel M. D.; Bretzel R. G.; Linn T. Vascular endothelial growth factor increases functional beta-cell mass by improvement of angiogenesis of isolated human and murine pancreatic islets. Transplantation 79:1530-1536; 2005.
23. Langlois A.; Bietiger W.; Mandes K.; Maillard E.; Belcourt A.; Pinget M.; Kessler L.; Sigrist S. Overexpression of vascular endothelial growth factor in vitro using deferoxamine: A new drug to increase islet vascularization during transplantation. Transplant. Proc. 40:473-476; 2008.
24. Langlois A.; Bietiger W.; Sencier M. C.; Maillard E.; Pinget M.; Kessler L.; Sigrist S. Adenoviral infection or deferoxamine? Two approaches to overexpress VEGF in beta-cell lines. J. Drug Target. 17:415-422; 2009.
25. Lau J.; Kampf C.; Mattsson G.; Nyqvist D.; Köhler M.; Berggren P. O.; Carlsson P. O. Beneficial role of pancreatic microenvironment for angiogenesis in transplanted pancreatic islets. Cell Transplant. 18:23-30; 2009.
26. Leibowitz G.; Beattie G. M.; Kafri T.; Cirulli V.; Lopez A. D.; Hayek A.; Levine F. Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes 48:745-753; 1999.
27. Lozier J. N.; Csako G.; Mondoro T. H.; Krizek D. M.; Metzger M. E.; Costello R.; Vostal J. G.; Rick M. E.; Donahue R. E.; Morgan R. A. Toxicity of a first-generation adenoviral vector in rhesus macaques. Hum. Gene Ther. 13:113-124; 2002.
28. Maillard E.; Sencier M. C.; Langlois A.; Bietiger W.; Krafft M. P.; Pinget M.; Sigrist S. Extracellular matrix proteins involved in pseudoislets formation. Islets 1(3):232-241; 2009.
29. Markel T. A.; Crisostomo P. R.; Wang M.; Herring C. M.; Meldrum K. K.; Lillemoe K. D.; Meldrum D. R. The struggle for iron: Gastrointestinal microbes modulate the host immune response during infection. J. Leukoc. Biol. 81:393-400; 2008.
30. Mattsson G.; Jansson L.; Carlsson P. O. Decreased vascular density in mouse pancreatic islets after transplantation. Diabetes 51:1362-1366; 2002.
31. Mendola J.; Wright, Jr. J. R.; Lacy P. E. Oxygen free-radical scavengers and immune destruction of murine islets in allograft rejection and multiple low-dose streptozocin-induced insulitis. Diabetes 38:379-385; 1989.
32. Menger M. D.; Yamauchi J.; Vollmar B. Revascularization and microcirculation of freely grafted islets of Langerhans. World J. Surg. 25:509-515; 2001.
33. Mukai E.; Fujimoto S.; Sakurai F.; Kawabata K.; Yamashita M.; Inagaki N.; Mizuguchi H. Efficient gene transfer into murine pancreatic islets using adenovirus vectors. J. Control. Release 119:136-141; 2007.
34. Muruve D. A. The innate immune response to adenovirus vectors. Hum. Gene Ther. 15: 1157-1166; 2004.
35. Noguchi H.; Naziruddin B.; Onaca N.; Jackson A.; Shimoda M.; Ikemoto T.; Fujita Y.; Kobayashi N.; Levy M. F.; Matsumoto S. Comparison of modified Celsior solution and m-kyoto solution for pancreas preservation in human islet isolation. Cell Transplant. 19:751-758; 2010.
36. Olejnicka B. T.; Andersson A.; Tyrberg B.; Dalen H.; Brunk U. T. Beta-cells, oxidative stress, lysosomal stability, and apoptotic/necrotic cell death. Antioxid. Redox. Signal 1:305-315; 1999.
37. Rodríguez-Mulero S.; Montanya E. Islet graft response to transplantation injury includes upregulation of protective as well as apoptotic genes. Cell Transplant. 17:1025-1034; 2008.
38. Rogée S.; Grellier E.; Bernard C.; Jouy N.; Loyens A.; Beauvillain J. C.; Fender P.; Corjon S.; Hong S. S.; Boulanger P.; Quesnel B.; D'Halluin J. C.; Colin M. Influence of chimeric human-bovine fibers on adenoviral uptake by liver cells and the antiviral immune response. Gene Ther. 17:880-891; 2010.
39. Ryan E. A.; Lakey J. R.; Paty B. W.; Imes S.; Korbutt G. S.; Kneteman N. M.; Bigam D.; Rajotte R. V.; Shapiro A. M. Successful islet transplantation: Continued insulin reserve provides long-term glycemic control. Diabetes 51:2148-2157; 2005.
40. Ryan E. A.; Lakey J. R.; Rajotte R. V.; Korbutt G. S.; Kin T.; Imes S.; Rabinovitch A.; Elliott J. F.; Bigam D.; Kneteman N. M.; Warnock G. L.; Larsen I.; Shapiro A. M. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50:710-719; 2001.
41. Ryan E. A.; Paty B. W. Five-year follow-up after clinical islet transplantation. Diabetes 54:2060-2069; 2005.
42. Sabek O. M.; Fraga D. W.; Henry J.; Gaber L. W.; Kotb M.; Gaber A. O. Expression of transforming growth factor-β by human islets: Impact on islet viability and function. Cell Transplant. 16:775-785; 2007.
43. Shapiro A. M.; Lakey J. R.; Ryan E. A.; Korbutt G. S.; Toth E.; Warnock G. L.; Kneteman N. M.; Rajotte R. V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343:289-290; 2000.
44. Shapiro A. M.; Ryan E. A.; Lakey J. R. Diabetes. Islet cell transplantation. Lancet 358(Suppl.):S21; 2001.
45. Sigalla J.; David A.; Anegon I.; Fiche M.; Huvelin J. M.; Boeffard F.; Cassard A.; Soulillou J. P.; Le Mauff B. Adenovirus-mediated gene transfer into isolated mouse adult pancreatic islets: Normal beta-cell function despite induction of an anti-adenovirus immune response. Hum. Gene Ther. 8:1625-1634; 1997.
46. Sigrist S.; Mechine-Neuville A.; Mandes K.; Calenda V.; Braun S.; Legeay G.; Bellocq J. P.; Pinget M.; Kessler L. Influence of VEGF on the viability of encapsulated pancreatic rat islets after transplantation in diabetic mice. Cell Transplant. 12:627-635; 2003.
47. Sutton R.; Peters M.; McShane P.; Gray D. W.; Morris P. J. Isolation of rat pancreatic islets by ductal injection of collagenase. Transplantation 42:689-691; 1986.
48. Vaithilingam V.; Oberholzer J.; Guillemin G. J.; Tuch B. E. Beneficial effects of desferrioxamine on encapsulated human islets-in vitro and in vivo study. Am. J. Transplant. 10:1961-1969; 2010.
49. Vasir B.; Aiello L. P.; Yoon K. H.; Quickel R. R.; Bonner-Weir S.; Weir G. C. Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells. Diabetes 47:1894-1903; 1998.
50. Vasir B.; Jonas J. C.; Steil G. M.; Hollister-Lock J.; Hasenkamp W.; Sharma A.; Bonner-Weir S.; Weir G. C. Gene expression of VEGF and its receptors Flk-1/KDR and Flt-1 in cultured and transplanted rat islets. Transplantation 71:924-935; 2001.
51. Vasir B.; Reitz P.; Xu G.; Sharma A.; Bonner-Weir S.; Weir G. C. Effects of diabetes and hypoxia on gene markers of angiogenesis (HGF, cMET, uPA and uPAR, TGF-alpha, TGF-beta, bFGF and Vimentin) in cultured and transplanted rat islets. Diabetologia 43:763-772; 2000.
52. Yancopoulos G. D.; Davis S.; Gale N. W.; Rudge J. S.; Wiegand S. J.; Holash J. Vascular-specific growth factors and blood vessel formation. Nature 407:242-248; 2000.
53. Zhang N.; Richter A.; Suriawinata J.; Harbaran S.; Altomonte J.; Cong L.; Zhang H.; Song K.; Meseck M.; Bromberg J.; Dong H. Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. Diabetes 53:963-970; 2004.